Literature DB >> 16988629

[Efficacy and efficiency of preoperative mydriasis: drops versus ocular insert].

T Caruba1, C Couffon-Partant, J Oliary, R Tadayoni, N Limelette, A Gaudric.   

Abstract

OBJECTIVE: The primary objective of this study was to compare eye drops and inserts in terms of the quality of preoperative mydriasis. The secondary objective was to evaluate the safety and ease of use of each modality. PATIENTS AND METHODS: Prospective randomized and simple blinded study. Patients were randomized into two groups: the insert protocol (atropine 1%, diclofenac 0.1% collyrium and Mydriasert) or the eye drop protocol (atropine 1%, diclofenac 0.1%, tropicamide 0.5%, and phenylephrine 10% collyrium). Fifty-one patients were included: 25 in the insert protocol and 26 in the drop protocol. Mydriasis quality was evaluated by nurses and surgeons. The ease of use was estimated by the number of gestures required to obtain mydriasis and the difficulties encountered. Safety was evaluated at the patient's bedside.
RESULTS: Mydriasis of at least 6 mm was obtained in 92% of the patients in the insert protocol (23/25) and 85% of the patients in the drop protocol (22/26) (NS). Four patients lost their insert during the study. Of the patients in the insert group, 16% (4/25) experienced stinging in their eyes, as did 23% (6/26) of patients in the group using drops (NS). To reach effective mydriasis, the insert protocol required fewer nurse gestures per patient than the drop protocol (3.0 versus 8.3; p<0.001).
CONCLUSION: With the protocol using an insert, preoperative mydriasis is not inferior to that obtained with drops only and is more efficient in terms of nurse time and number of gestures. Nurses should be trained in appropriate handling of the insert and avoiding the loss of the device.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16988629     DOI: 10.1016/s0181-5512(06)73848-7

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  4 in total

1.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

2.  Mydriasert pupillary dilation for cataract surgery: an economic and clinical study.

Authors:  Ameet Shah; Sukhvinder Johal; Nicholas Lee
Journal:  BMC Ophthalmol       Date:  2015-06-03       Impact factor: 2.209

3.  In Situ Gelling Ophthalmic Drug Delivery System for the Optimization of Diagnostic and Preoperative Mydriasis: In Vitro Drug Release, Cytotoxicity and Mydriasis Pharmacodynamics.

Authors:  Pierre-Louis Destruel; Ni Zeng; Françoise Brignole-Baudouin; Sophie Douat; Johanne Seguin; Elodie Olivier; Melody Dutot; Patrice Rat; Sophie Dufaÿ; Amélie Dufaÿ-Wojcicki; Marc Maury; Nathalie Mignet; Vincent Boudy
Journal:  Pharmaceutics       Date:  2020-04-15       Impact factor: 6.321

4.  Use of a new ocular insert versus conventional mydriasis in cataract surgery.

Authors:  C Torrón; P Calvo; O Ruiz-Moreno; J Leciñena; A Pérez-Iñigo
Journal:  Biomed Res Int       Date:  2013-05-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.